U.S. market Open. Closes in 2 hours 50 minutes

ABT | Abbott Laboratories Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for ABT we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is very good and Health is frighteningly weak.

Valuation (48%)

Company Industry
P/E Ratio (TTM) 34.37 47.85
PEG Ratio (TTM) 10.03 -0.77
P/S Ratio (TTM) 4.79 6.10
P/B Ratio (TTM) N/A 6.12
P/FCF Ratio (TTM) 45.49 42.18
Price to 5YR AVG Earnings Ratio 35.78 59.80
Price to 5YR AVG FCF Ratio 31.09 34.34

Profitability (45%)

Company Industry
ROA (TTM) N/A 5.29%
ROE (TTM) 19.76% 27.69%
Net Profit Margin (TTM) 13.99% 7.92%
ROIC 5YR AVG 14.49% 6.68%

Growth (72%)

4QTR AVG 3YR AVG 5YR AVG
EPS 4.75% 44.20% 23.12%
Revenue 1.22% 12.43% 6.10%
Net Income 5.14% 44.98% 23.10%
Cash Flow -3.30% 19.83% 5.24%

Health (30%)

Company Industry
Current Ratio (TTM) N/A 2.88
Quick Ratio (TTM) N/A 2.15
D/E Ratio (TTM) N/A 0.62
Interest Coverage (TTM) 17.03 23.32
Piotroski F-Score 7 6
Altman Z-Score N/A 7.57
LTL to 5YR AVG FCF 2.14 3.50
Shares Outstanding Growth 5YR AVG -0.18% 1.64%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙